| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0006-8993(76)90502-3 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0006899376905023?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:0006899376905023?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 10053 |
| P50 | author | Leslie Iversen | Q15825712 |
| Edward D. Bird | Q84176647 | ||
| P2093 | author name string | S. H. Snyder | |
| Bennett JP Jr | |||
| J. P. Bennett | |||
| L. L. Iversen | |||
| S. J. Enna | |||
| D. B. Bylund | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Acetylcholine receptors. Distribution and extrajunctional density in rat diaphragm after denervation correlated with acetylcholine sensitivity | Q36428683 | ||
| Muscarinic cholinergic binding in rat brain | Q37442793 | ||
| Direct identification and characterisation of β-adrenergic receptors in rat brain | Q39065151 | ||
| Neurotransmitter Receptors in the Brain: Biochemical Identification | Q39085874 | ||
| Huntington's chorea. Changes in neurotransmitter receptors in the brain | Q39090681 | ||
| Huntington's disease: Treatment with dipropylacetic acid and gamma-aminobutyric acid | Q39755094 | ||
| Regional distribution of postsynaptic receptor binding for gamma-aminobutyric acid (GABA) in monkey brain | Q39936310 | ||
| Stereospecific binding ofd-lysergic acid diethylamide (LSD) to brain membranes: Relationship to serotonin receptors | Q40337442 | ||
| Properties of γ-aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions | Q40346759 | ||
| Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain | Q42438675 | ||
| Origin and distribution of glutamate decarboxylase in substantia nigra of the cat. | Q43528658 | ||
| Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia | Q45300939 | ||
| Central cholinergic-anticholinergic antagonism in Huntington's chorea | Q45302238 | ||
| Biochemical abnormalities in Huntington's chorea brains | Q45302938 | ||
| Decreased muscarinic receptor concentration in post-mortem brain in Huntington's chorea | Q45302987 | ||
| Postsynaptic localization of muscarinic cholinergic receptor binding in rat hippocampus | Q47838397 | ||
| Light autoradiographic localisation of cholinergic muscarinic receptors in rat brain by specific binding of a potent antagonist | Q48476174 | ||
| D-LSD binding to brain homogenates: Possible relationship to serotonin receptors | Q48499078 | ||
| In vivo identification of muscarinic cholinergic receptor binding in rat brain | Q48506704 | ||
| MICRODETERMINATION OF CHOLINE ACETYLASE IN NERVOUS TISSUE | Q51252728 | ||
| Huntington's disease. | Q52720004 | ||
| Massachusetts Medical Society. Impact of the regulatory process on medical practice in Massachusetts | Q66960955 | ||
| [The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis] | Q67224247 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurotransmitter | Q162657 |
| Huntington's disease | Q190564 | ||
| P1104 | number of pages | 7 | |
| P304 | page(s) | 531-537 | |
| P577 | publication date | 1976-11-01 | |
| 1976-11-12 | |||
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | Alterations of brain neurotransmitter receptor binding in Huntington's chorea | |
| P478 | volume | 116 |
| Q40248085 | 3 HGABA Binding in Brains from Huntington's Chorea Patients: Altered Regulation by Phospholipids? |
| Q45295988 | 5-HT1B receptor binding in degenerative movement disorders |
| Q43648298 | Age differences in muscarinic cholinergic receptors assayed with (+)N-[(11)C]methyl-3-piperidyl benzilate in the brains of conscious monkeys |
| Q40100876 | Alterations in 3H-GABA binding in Huntington's chorea |
| Q39242585 | Alterations in the benzodiazepine receptor of Huntington's diseased human brain |
| Q40215778 | An analysis of [3H]gamma-aminobutyric acid (GABA) binding in the human brain |
| Q66706740 | Autoimmunity in diabetes |
| Q45303735 | Basal ganglia disease |
| Q67020109 | Behavioral differences induced by muscimol selectively injected into pars compacta and pars reticulata of Substantia Nigra |
| Q40139291 | Biochemical and Electrophysiological Characteristics of Mammalian Gaba Receptors |
| Q40251117 | Biochemical evidence for two classes of GABA receptors in rat brain |
| Q42446821 | Biochemical evidence of selective nerve cell changes in the normal ageing human and rat brain. |
| Q34982070 | Biochemistry of Dementias |
| Q40113701 | Central nervous system receptors in neuropsychiatric disorders |
| Q39640540 | Cerebrospinal fluid gamma-aminobutyric acid: daily pattern and response to haloperidol |
| Q37507773 | Cholinergic Interneurons Amplify Corticostriatal Synaptic Responses in the Q175 Model of Huntington's Disease. |
| Q49123551 | Classical and non-classical neuroleptics induce supersensitivity of nigral GABA-ergic mechanisms in the rat |
| Q40192106 | Clinical, neuropathologic and pharmacologic aspects of Huntington's disease: Correlates with a new animal model |
| Q40191450 | Denervation supersensitivity in the striatonigral GABA pathway |
| Q40085825 | Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications |
| Q48632475 | Early undernutrition and [3H]gamma-aminobutyric acid binding in rat brain |
| Q33942589 | Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in [...] |
| Q31949201 | Evaluation of novel PET ligands (+)N-[11C]methyl-3-piperidyl benzilate ([11C](+)3-MPB) and its stereoisomer [11C](-)3-MPB for muscarinic cholinergic receptors in the conscious monkey brain: a PET study in comparison with |
| Q72882102 | GABA as the pallidothalamic neurotransmitter: implications for basal ganglia function |
| Q40136120 | GABA binding processes and behavior |
| Q40125384 | GABA-Benzodiazepine-Barbiturate Receptor Interactions |
| Q40246307 | Gamma-aminobutyric acid receptor binding in human brain regions |
| Q35612951 | Human serum Cohn fraction IV (alpha-globulin [correction of globin] enriched) inhibits ligand binding at neurotransmitter receptors in human brain |
| Q39868261 | Huntington'S disease: Treatment with muscimol, A GABA-mimetic drug |
| Q28324314 | In vivo Muscarinic Cholingeric Receptor Imaging in Human Brain with [11C]Scopolamine and Positron Emission Tomography |
| Q67278437 | Increased Binding of [3H]GABA to Striatal Membranes Following Ischemia |
| Q39868254 | Inhibitors of GABA metabolism: Implications for Huntington's disease |
| Q48828369 | Involvement of GABA systems in feedback regulation of glutamate-and GABA-mediated synaptic potentials in rat neostriatum |
| Q45305927 | Membrane Anomalies in Huntington's Disease Fibroblasts |
| Q48319379 | Necropsy evidence of central cholinergic deficits in senile dementia |
| Q39428914 | Neocortical cholinergic neurons in elderly people |
| Q40096918 | Neurochemical Anatomy of Movement Disorders |
| Q49126499 | Neuronal responses to iontophoretically applied dopamine, glutamate, and GABA of identified dopaminergic cells in the rat substantia nigra after kainic acid-induced destruction of the striatum |
| Q34708171 | Neurotoxicity of folates: Implications for vitamin B12 deficiency and Huntington's chorea |
| Q40093350 | Neurotransmitter receptor alterations in Parkinson's disease |
| Q72479483 | Neurotransmitter receptors in brain in schizophrenia |
| Q45303775 | Neurotransmitters in Huntington's Chorea—a Clinician's View |
| Q49091501 | Nigral actions of GABA agonists are enhanced by chronic fluphenazine and differentiated by concomitant flurazepam |
| Q48931169 | Post-mortem high affinity glutamate uptake in human brain |
| Q40196582 | Pre- and postsynaptic neurochemical alterations in Alzheimer's disease |
| Q47976364 | Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding |
| Q72889679 | Reduced glycine receptor in the spinal cord in amyotrophic lateral sclerosis |
| Q37998888 | Regulation of Central Adrenergic Receptors |
| Q39551919 | Serotonin in involuntary movement disorders |
| Q26863113 | Striatal cholinergic interneuron regulation and circuit effects |
| Q45305735 | Substantia Nigra ?-Aminobutyric Acid Receptors in Huntington's Disease |
| Q40127250 | The GABA postsynaptic membrane receptor-ionophore complex. Site of action of convulsant and anticonvulsant drugs |
| Q70132673 | The aging brain |
| Q39864691 | The brain in Huntington's chorea |
| Q45300428 | The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease |
| Q40082826 | The physiology and pharmacology of mammalian basal ganglia |
| Q38075185 | The striatum and substantia nigra: A commentary on their relationships |
| Q39789009 | Vertebrate GABA receptors |
Search more.